SIGHT SCIENCES, INC. Deferred Costs, Current
SIGHT SCIENCES, INC. (SGHT) had Deferred Costs, Current of $4.50 million as of 2021-07-31, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Deferred Costs, Current
us-gaap:DeferredCostsCurrent · last filed 2021-11-10
- 2021-07-31: Deferred Costs, Current $4.50M.
| Period end | Deferred Costs, Current |
|---|---|
| 2021-07-31 | $4.50M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |